Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | English |
| Veröffentlicht: |
Copenhagen
Munksgaard
1993
|
| Schriftenreihe: | APMIS / Supplementum
35 |
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV008426834 | ||
| 003 | DE-604 | ||
| 005 | 19961118 | ||
| 007 | t| | ||
| 008 | 931222s1993 xx d||| m||| 00||| eng d | ||
| 020 | |a 8716150589 |9 87-16-15058-9 | ||
| 035 | |a (OCoLC)29747137 | ||
| 035 | |a (DE-599)BVBBV008426834 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-19 |a DE-12 |a DE-188 |a DE-578 | ||
| 050 | 0 | |a R81 | |
| 082 | 0 | |a 616.05 |b A1105, suppL. no.35 | |
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Gautier Hermann, Gregers |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma |c by Gregers Gautier Hermann |
| 264 | 1 | |a Copenhagen |b Munksgaard |c 1993 | |
| 300 | |a 26 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a APMIS / Supplementum |v 35 | |
| 500 | |a Zsfassung in dän. Sprache. - Zugl.: Kopenhagen, Univ., Diss., 1993 | ||
| 502 | |a Zugl.: Copenhagen, Univ., Diss., 1993 | ||
| 650 | 7 | |a Blaaskanker |2 gtt | |
| 650 | 7 | |a Interleukine-2 |2 gtt | |
| 650 | 7 | |a Nierceltumoren |2 gtt | |
| 650 | 4 | |a Bladder Neoplasms |x drug therapy | |
| 650 | 4 | |a Bladder |x Cancer |x Treatment | |
| 650 | 4 | |a Carcinoma, Renal Cell |x drug therapy | |
| 650 | 4 | |a Interleukin-2 | |
| 650 | 4 | |a Kidneys |x Cancer |x Treatment | |
| 650 | 0 | 7 | |a Tumormarker |0 (DE-588)4117262-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Interleukin 2 |0 (DE-588)4162018-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hypernephrom |0 (DE-588)4161076-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Prognose |0 (DE-588)4047390-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Blasenkrebs |0 (DE-588)4007032-3 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Interleukin 2 |0 (DE-588)4162018-5 |D s |
| 689 | 0 | 1 | |a Blasenkrebs |0 (DE-588)4007032-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Interleukin 2 |0 (DE-588)4162018-5 |D s |
| 689 | 1 | 1 | |a Hypernephrom |0 (DE-588)4161076-3 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Blasenkrebs |0 (DE-588)4007032-3 |D s |
| 689 | 2 | 1 | |a Interleukin 2 |0 (DE-588)4162018-5 |D s |
| 689 | 2 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 2 | 3 | |a Prognose |0 (DE-588)4047390-9 |D s |
| 689 | 2 | 4 | |a Tumormarker |0 (DE-588)4117262-0 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Hypernephrom |0 (DE-588)4161076-3 |D s |
| 689 | 3 | 1 | |a Interleukin 2 |0 (DE-588)4162018-5 |D s |
| 689 | 3 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 3 | 3 | |a Prognose |0 (DE-588)4047390-9 |D s |
| 689 | 3 | 4 | |a Tumormarker |0 (DE-588)4117262-0 |D s |
| 689 | 3 | |5 DE-604 | |
| 810 | 2 | |a Supplementum |t APMIS |v 35 |w (DE-604)BV009899447 |9 35 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-005551402 | |
Datensatz im Suchindex
| DE-19_call_number | 0760/8 Med.GZ 325s(32/39 |
|---|---|
| DE-19_location | 55 |
| DE-BY-UBM_katkey | 1244489 |
| DE-BY-UBM_local_keycode | di |
| DE-BY-UBM_media_number | 99991395564 |
| DE-BY-UBR_call_number | 00/XA 13162 24/X30438 |
| DE-BY-UBR_katkey | 2026249 |
| DE-BY-UBR_location | 00 |
| DE-BY-UBR_media_number | TEMP2649884 069018219034 |
| _version_ | 1823050817545961472 |
| any_adam_object | |
| author | Gautier Hermann, Gregers |
| author_facet | Gautier Hermann, Gregers |
| author_role | aut |
| author_sort | Gautier Hermann, Gregers |
| author_variant | h g g hg hgg |
| building | Verbundindex |
| bvnumber | BV008426834 |
| callnumber-first | R - Medicine |
| callnumber-label | R81 |
| callnumber-raw | R81 |
| callnumber-search | R81 |
| callnumber-sort | R 281 |
| callnumber-subject | R - General Medicine |
| ctrlnum | (OCoLC)29747137 (DE-599)BVBBV008426834 |
| dewey-full | 616.05 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.05 |
| dewey-search | 616.05 |
| dewey-sort | 3616.05 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02729nam a2200733 cb4500</leader><controlfield tag="001">BV008426834</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19961118 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">931222s1993 xx d||| m||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">8716150589</subfield><subfield code="9">87-16-15058-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)29747137</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008426834</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R81</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.05</subfield><subfield code="b">A1105, suppL. no.35</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gautier Hermann, Gregers</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma</subfield><subfield code="c">by Gregers Gautier Hermann</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Copenhagen</subfield><subfield code="b">Munksgaard</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">26 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">APMIS / Supplementum</subfield><subfield code="v">35</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Zsfassung in dän. Sprache. - Zugl.: Kopenhagen, Univ., Diss., 1993</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="a">Zugl.: Copenhagen, Univ., Diss., 1993</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Blaaskanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Interleukine-2</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nierceltumoren</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bladder Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bladder</subfield><subfield code="x">Cancer</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carcinoma, Renal Cell</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interleukin-2</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Kidneys</subfield><subfield code="x">Cancer</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumormarker</subfield><subfield code="0">(DE-588)4117262-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Interleukin 2</subfield><subfield code="0">(DE-588)4162018-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hypernephrom</subfield><subfield code="0">(DE-588)4161076-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prognose</subfield><subfield code="0">(DE-588)4047390-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Blasenkrebs</subfield><subfield code="0">(DE-588)4007032-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Interleukin 2</subfield><subfield code="0">(DE-588)4162018-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Blasenkrebs</subfield><subfield code="0">(DE-588)4007032-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Interleukin 2</subfield><subfield code="0">(DE-588)4162018-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Hypernephrom</subfield><subfield code="0">(DE-588)4161076-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Blasenkrebs</subfield><subfield code="0">(DE-588)4007032-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Interleukin 2</subfield><subfield code="0">(DE-588)4162018-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="3"><subfield code="a">Prognose</subfield><subfield code="0">(DE-588)4047390-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="4"><subfield code="a">Tumormarker</subfield><subfield code="0">(DE-588)4117262-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Hypernephrom</subfield><subfield code="0">(DE-588)4161076-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Interleukin 2</subfield><subfield code="0">(DE-588)4162018-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="3"><subfield code="a">Prognose</subfield><subfield code="0">(DE-588)4047390-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="4"><subfield code="a">Tumormarker</subfield><subfield code="0">(DE-588)4117262-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplementum</subfield><subfield code="t">APMIS</subfield><subfield code="v">35</subfield><subfield code="w">(DE-604)BV009899447</subfield><subfield code="9">35</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005551402</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV008426834 |
| illustrated | Illustrated |
| indexdate | 2025-02-03T16:22:41Z |
| institution | BVB |
| isbn | 8716150589 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005551402 |
| oclc_num | 29747137 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-12 DE-188 DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-12 DE-188 DE-578 |
| physical | 26 S. graph. Darst. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Munksgaard |
| record_format | marc |
| series2 | APMIS / Supplementum |
| spellingShingle | Gautier Hermann, Gregers Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma Blaaskanker gtt Interleukine-2 gtt Nierceltumoren gtt Bladder Neoplasms drug therapy Bladder Cancer Treatment Carcinoma, Renal Cell drug therapy Interleukin-2 Kidneys Cancer Treatment Tumormarker (DE-588)4117262-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd Interleukin 2 (DE-588)4162018-5 gnd Hypernephrom (DE-588)4161076-3 gnd Prognose (DE-588)4047390-9 gnd Blasenkrebs (DE-588)4007032-3 gnd |
| subject_GND | (DE-588)4117262-0 (DE-588)4076066-2 (DE-588)4162018-5 (DE-588)4161076-3 (DE-588)4047390-9 (DE-588)4007032-3 (DE-588)4113937-9 |
| title | Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma |
| title_auth | Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma |
| title_exact_search | Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma |
| title_full | Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma by Gregers Gautier Hermann |
| title_fullStr | Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma by Gregers Gautier Hermann |
| title_full_unstemmed | Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma by Gregers Gautier Hermann |
| title_short | Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma |
| title_sort | studies of the immunological effects of interleukin 2 in patients with bladder cancer and renal cell carcinoma |
| topic | Blaaskanker gtt Interleukine-2 gtt Nierceltumoren gtt Bladder Neoplasms drug therapy Bladder Cancer Treatment Carcinoma, Renal Cell drug therapy Interleukin-2 Kidneys Cancer Treatment Tumormarker (DE-588)4117262-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd Interleukin 2 (DE-588)4162018-5 gnd Hypernephrom (DE-588)4161076-3 gnd Prognose (DE-588)4047390-9 gnd Blasenkrebs (DE-588)4007032-3 gnd |
| topic_facet | Blaaskanker Interleukine-2 Nierceltumoren Bladder Neoplasms drug therapy Bladder Cancer Treatment Carcinoma, Renal Cell drug therapy Interleukin-2 Kidneys Cancer Treatment Tumormarker Pharmakotherapie Interleukin 2 Hypernephrom Prognose Blasenkrebs Hochschulschrift |
| volume_link | (DE-604)BV009899447 |
| work_keys_str_mv | AT gautierhermanngregers studiesoftheimmunologicaleffectsofinterleukin2inpatientswithbladdercancerandrenalcellcarcinoma |